ArticleJournal of virology2012

A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaques.

Brian Moldt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.